Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and tolerability of neoadjuvant therapy with Tal... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial)
0
Authors
Julia Ressler
•
Maud Plaschka
17 more
•
Christoph Höeller
Published
January 16, 2025
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Cancer
Topics
Cancer Oncology
Epidemiology
Internal Medicine
Medicine
Cancer Oncology
Epidemiology
Internal Medicine
Genetics
Show all topics
DOI
10.1038/s43018-024-00879-x
License
CC-BY-NC-ND
